Kasim Kutay is a Member of the Board at Novo Nordisk. Kasim has previously worked as Gimv, CW+ Chelsea and Westminster Hospital NHS Foundation Trust, ConvaTec, Novo Nordisk, Novozymes, Novo Holdings, and Moelis & Company.
Kutay has a long history of working in finance and investments. Kasim started their career at Moelis & Company in 2009 as a partner and co-head of Europe. Kasim was with the company for seven years before leaving in 2016 to join NORTHWICK PARK INSTITUTE FOR MEDICAL RESEARCH as a trustee.
Kutay has also been involved with SOAS University of London as a member of the investment committee overseeing the university endowment.
Kasim Kutay has a MSc and a BSc in Economics from The London School of Economics and Political Science (LSE).